US Stock MarketDetailed Quotes

KYMR Kymera Therapeutics

Watchlist
  • 33.370
  • +0.020+0.06%
Close Apr 26 16:00 ET
2.05BMarket Cap-13242P/E (TTM)

Kymera Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
67.84%78.59M
196.70%47.89M
-50.50%4.73M
43.42%16.51M
-1.62%9.47M
-35.71%46.83M
5.66%16.14M
-53.03%9.55M
-37.83%11.51M
-48.55%9.62M
Operating revenue
67.84%78.59M
196.70%47.89M
-50.50%4.73M
43.42%16.51M
-1.62%9.47M
-35.71%46.83M
5.66%16.14M
-53.03%9.55M
-37.83%11.51M
-48.55%9.62M
Cost of revenue
Gross profit
Operating expense
17.32%244.12M
22.69%67.2M
14.34%62.24M
14.47%59.9M
17.69%54.79M
20.03%208.08M
11.16%54.77M
11.15%54.43M
20.98%52.32M
46.07%46.56M
Selling and administrative expenses
25.57%55.04M
22.27%14.23M
33.76%14.12M
28.08%14.13M
18.41%12.57M
20.61%43.83M
-0.89%11.64M
-1.04%10.56M
37.39%11.03M
79.57%10.61M
-General and administrative expense
25.57%55.04M
22.27%14.23M
33.76%14.12M
28.08%14.13M
18.41%12.57M
20.61%43.83M
-0.89%11.64M
-1.04%10.56M
37.39%11.03M
79.57%10.61M
Research and development costs
15.12%189.08M
22.81%52.97M
9.66%48.12M
10.83%45.77M
17.48%42.23M
19.87%164.25M
14.93%43.13M
14.54%43.88M
17.24%41.29M
38.45%35.94M
Operating profit
-2.65%-165.53M
50.01%-19.31M
-28.13%-57.51M
-6.30%-43.38M
-22.72%-45.33M
-60.41%-161.26M
-13.64%-38.63M
-56.73%-44.88M
-65.02%-40.81M
-180.45%-36.93M
Net non-operating interest income expense
187.97%18.57M
31.31%4.94M
146.91%4.64M
728.93%4.58M
1,666.27%4.4M
1,960.06%6.45M
3,905.32%3.77M
3,318.18%1.88M
690.00%553K
164.89%249K
Non-operating interest income
183.27%18.76M
30.65%5M
144.42%4.68M
679.80%4.63M
1,435.52%4.45M
1,257.38%6.62M
2,537.24%3.82M
1,432.80%1.92M
506.12%594K
145.76%290K
Non-operating interest expense
11.36%196K
-11.86%52K
13.89%41K
17.07%48K
34.15%55K
0.57%176K
15.69%59K
-48.57%36K
46.43%41K
70.83%41K
Other net income (expense)
Income before tax
5.07%-146.96M
58.79%-14.37M
-22.94%-52.87M
3.62%-38.8M
-11.57%-40.93M
-54.47%-154.81M
-2.85%-34.87M
-50.45%-43M
-63.25%-40.26M
-180.57%-36.68M
Income tax
Net income
5.07%-146.96M
58.79%-14.37M
-22.94%-52.87M
3.62%-38.8M
-11.57%-40.93M
-54.47%-154.81M
-2.85%-34.87M
-50.45%-43M
-63.25%-40.26M
-180.57%-36.68M
Net income continuous Operations
5.07%-146.96M
58.79%-14.37M
-22.94%-52.87M
3.62%-38.8M
-11.57%-40.93M
-54.47%-154.81M
-2.85%-34.87M
-50.45%-43M
-63.25%-40.26M
-180.57%-36.68M
Minority interest income
Net income attributable to the parent company
5.07%-146.96M
58.79%-14.37M
-22.94%-52.87M
3.62%-38.8M
-11.57%-40.93M
-54.47%-154.81M
-2.85%-34.87M
-50.45%-43M
-63.25%-40.26M
-180.57%-36.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
5.07%-146.96M
58.79%-14.37M
-22.94%-52.87M
3.62%-38.8M
-11.57%-40.93M
-54.47%-154.81M
-2.85%-34.87M
-50.45%-43M
-63.25%-40.26M
-180.57%-36.68M
Basic earnings per share
12.20%-2.52
58.33%-0.25
-13.92%-0.9
14.10%-0.67
1.41%-0.7
-37.32%-2.87
9.09%-0.6
-41.07%-0.79
-41.82%-0.78
-144.83%-0.71
Diluted earnings per share
12.20%-2.52
58.33%-0.25
-13.92%-0.9
14.10%-0.67
1.41%-0.7
-37.32%-2.87
9.09%-0.6
-41.07%-0.79
-41.82%-0.78
-144.83%-0.71
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 67.84%78.59M196.70%47.89M-50.50%4.73M43.42%16.51M-1.62%9.47M-35.71%46.83M5.66%16.14M-53.03%9.55M-37.83%11.51M-48.55%9.62M
Operating revenue 67.84%78.59M196.70%47.89M-50.50%4.73M43.42%16.51M-1.62%9.47M-35.71%46.83M5.66%16.14M-53.03%9.55M-37.83%11.51M-48.55%9.62M
Cost of revenue
Gross profit
Operating expense 17.32%244.12M22.69%67.2M14.34%62.24M14.47%59.9M17.69%54.79M20.03%208.08M11.16%54.77M11.15%54.43M20.98%52.32M46.07%46.56M
Selling and administrative expenses 25.57%55.04M22.27%14.23M33.76%14.12M28.08%14.13M18.41%12.57M20.61%43.83M-0.89%11.64M-1.04%10.56M37.39%11.03M79.57%10.61M
-General and administrative expense 25.57%55.04M22.27%14.23M33.76%14.12M28.08%14.13M18.41%12.57M20.61%43.83M-0.89%11.64M-1.04%10.56M37.39%11.03M79.57%10.61M
Research and development costs 15.12%189.08M22.81%52.97M9.66%48.12M10.83%45.77M17.48%42.23M19.87%164.25M14.93%43.13M14.54%43.88M17.24%41.29M38.45%35.94M
Operating profit -2.65%-165.53M50.01%-19.31M-28.13%-57.51M-6.30%-43.38M-22.72%-45.33M-60.41%-161.26M-13.64%-38.63M-56.73%-44.88M-65.02%-40.81M-180.45%-36.93M
Net non-operating interest income expense 187.97%18.57M31.31%4.94M146.91%4.64M728.93%4.58M1,666.27%4.4M1,960.06%6.45M3,905.32%3.77M3,318.18%1.88M690.00%553K164.89%249K
Non-operating interest income 183.27%18.76M30.65%5M144.42%4.68M679.80%4.63M1,435.52%4.45M1,257.38%6.62M2,537.24%3.82M1,432.80%1.92M506.12%594K145.76%290K
Non-operating interest expense 11.36%196K-11.86%52K13.89%41K17.07%48K34.15%55K0.57%176K15.69%59K-48.57%36K46.43%41K70.83%41K
Other net income (expense)
Income before tax 5.07%-146.96M58.79%-14.37M-22.94%-52.87M3.62%-38.8M-11.57%-40.93M-54.47%-154.81M-2.85%-34.87M-50.45%-43M-63.25%-40.26M-180.57%-36.68M
Income tax
Net income 5.07%-146.96M58.79%-14.37M-22.94%-52.87M3.62%-38.8M-11.57%-40.93M-54.47%-154.81M-2.85%-34.87M-50.45%-43M-63.25%-40.26M-180.57%-36.68M
Net income continuous Operations 5.07%-146.96M58.79%-14.37M-22.94%-52.87M3.62%-38.8M-11.57%-40.93M-54.47%-154.81M-2.85%-34.87M-50.45%-43M-63.25%-40.26M-180.57%-36.68M
Minority interest income
Net income attributable to the parent company 5.07%-146.96M58.79%-14.37M-22.94%-52.87M3.62%-38.8M-11.57%-40.93M-54.47%-154.81M-2.85%-34.87M-50.45%-43M-63.25%-40.26M-180.57%-36.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 5.07%-146.96M58.79%-14.37M-22.94%-52.87M3.62%-38.8M-11.57%-40.93M-54.47%-154.81M-2.85%-34.87M-50.45%-43M-63.25%-40.26M-180.57%-36.68M
Basic earnings per share 12.20%-2.5258.33%-0.25-13.92%-0.914.10%-0.671.41%-0.7-37.32%-2.879.09%-0.6-41.07%-0.79-41.82%-0.78-144.83%-0.71
Diluted earnings per share 12.20%-2.5258.33%-0.25-13.92%-0.914.10%-0.671.41%-0.7-37.32%-2.879.09%-0.6-41.07%-0.79-41.82%-0.78-144.83%-0.71
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg